Beranda › Kondisi Pasca-COVID (Long COVID) › Missouri
Uji klinis Kondisi Pasca-COVID (Long COVID) di Missouri
4 studi untuk Kondisi Pasca-COVID (Long COVID) mencari peserta di lokasi di Missouri.
Kota di Missouri
Teks studi resmi (Bahasa Inggris)
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
- Saint Louis University Center for Vaccine Development, St Louis
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07536308Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Kansas City
- Research Site, St Louis
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
- Washington University in Saint Louis Department of Emergency Medicine, Emergency Care Research Core, St Louis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT06848309EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
- St. Louis Children's Hospital, St Louis
- Washington University School of Medicine, St Louis
Menerima pesertaFase 3
Usia 0 hingga 17 · Semua jenis kelamin · Diperbarui 17 Jul 2025 · NCT05261139Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.